ClinicalTrialsFinder

Relapse Acute Myeloid Leukemia Clinical Trials in Beijing

1 recruitingBeijing, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML

AMLRefractory/Relapse Acute Myeloid Leukemia
Peking University People's Hospital27 enrolled1 locationNCT07617285